Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Jefferies lowers Fortrea shares target citing revised financial outlook

EditorEmilio Ghigini
Published 2024-05-20, 06:26 a/m
FTRE
-

On Monday, Jefferies adjusted its financial outlook on Fortrea (NASDAQ:FTRE) shares, a company traded on the NASDAQ stock exchange. The firm reduced its price target for Fortrea to $36.50, a decrease from the previous target of $44.00. Despite the lowered target, Jefferies continues to recommend a Buy rating for the stock.

The revision follows Fortrea's report of a challenging first quarter, which included revenue declines, low profit margins, and a downward revision of future guidance. The company's spending has decreased more than anticipated, given the increase in its oncology and biotech segments.

The new projections set by Fortrea indicate a significant increase in revenue and margins, which the analyst describes as somewhat ambitious, especially if business-to-business (B2B) transactions increase by 1.2 times.

Even with a conservative outlook that falls below the company's own guidance, Jefferies has applied a modest valuation multiple to Fortrea's anticipated 2025 earnings before interest, taxes, depreciation, and amortization (EBITDA).

This valuation, which includes a 28% discount compared to Fortrea's peers, supports the new price target of $36.50. The firm's stance remains positive on the stock with the continuation of a Buy rating.

The price target adjustment reflects Jefferies' analysis of Fortrea's financial performance and future expectations. The firm has taken into account the slower burn rate and the potential for growth in the company's key business areas to arrive at the new price target. Despite the setbacks observed in the first quarter, Jefferies appears to see long-term value in Fortrea's stock at the adjusted price level.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.